InvestmentApr 28, 2026, 03:49 PM
NRSN Announces Pricing of Insider-Led PIPE Financing
AI Summary
NeuroSense Therapeutics Ltd. announced the pricing of an insider-led Private Investment in Public Equity (PIPE) financing. This development was communicated via a press release issued on April 28, 2026, which is included as Exhibit 99.1 in the company's Form 6-K filing.
Key Highlights
- NeuroSense Therapeutics announced the pricing of an insider-led PIPE financing.
- A press release detailing the financing was issued on April 28, 2026.
- The press release is furnished as Exhibit 99.1 to the Form 6-K filing.
Price Impact
More from NRSN